Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|December 23, 2023
Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ayman Abouzayed, et al.
International Journal of Molecular Sciences|February 27, 2026
Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical ModelVladimir Tolmachev, Amelinda Janice Herlina, Eleftherios Papalanis, et al.
Molecular Medicine Reports|January 8, 2024
Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linkerFanny Lundmark, Anzhelika Vorobyeva, Yongsheng Liu, et al.
Molecular Pharmaceutics|November 22, 2017
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor OverexpressionDominik Summer, Javad Garousi, Maryam Oroujeni, et al.
Cancers|February 2, 2021
Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based PretargetingHanna Tano, Maryam Oroujeni, Anzhelika Vorobyeva, et al.
Pharmaceutics|November 27, 2021
Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity ProteinJavad Garousi, Haozhong Ding, Emma von Witting, et al.
Amino Acids|May 6, 2018
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of 99mTc-labeled anti-EGFR affibody moleculesMaryam Oroujeni, Ken G Andersson, Xenia Steinhardt, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody MoleculesVladimir Tolmachev, Eleftherios Papalanis, Ekaterina A Bezverkhniaia, et al.
Pharmaceutics|July 27, 2022
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECTYongsheng Liu, Shengze Yu, Tianqi Xu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 15, 2019
Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6Emma von Witting, Javad Garousi, Sarah Lindbo, et al.
Pageof 5